Monthly Archives: December 2017

As we come to the end 2017, here is a summary of the most popular* items from the past year. CETA and NAFTA were of the most interest with four of the top five posts relating to the Eli Lilly NAFTA arbitration decision and the implementation of changes to the PM(NOC) Regulations and geographic indicators:

As we come to the end of another year, I would like to thank all my IPPractice subscribers, currently approximately 1600. I would also like to remind you to check out your subscription preferences to take advantage of some of the features available, including:

Due to changes with the Federal Court and Federal Court of Appeal websites to restricted automated access, there are still no updates on watched files. Today’s IPPractice daily email contains a list of all new proceedings from last week, as well as today.

There are reports today that Barry Sherman and his wife Honey were found dead in their home in Toronto. Barry Sherman was the founder of generic pharmaceutical company Apotex Inc, a significant player in the pharmaceutical industry both in Canada and abroad. Apotex has been a party to many patent litigation proceedings including on many of the leading decisions on patent law.

Amendments to the Industrial Design Regulations have been published in the Canada Gazette, Part 1. The changes are primarily directed to implementing the Hague Agreement. Consultation is open until January 8, 2018.

Proposed “Regulations Amending the Patented Medicines Regulations” have been published in the Canada Gazette for a 75 day consultation. According to the Regulatory Impact Analysis Statement, “This proposal would amend the Patented Medicines Regulations (“Regulations”) so that the PMPRB’s regulatory framework includes new price regulatory factors and patentee price information reporting requirements that will help the PMPRB to protect Canadian consumers from excessive prices.”

Recent Posts

Contributions

Blog

About Me

I am a partner at DLA Piper (Canada) LLP practicing in the area of intellectual property. Material on this website are my own views and do not reflect the position of DLA Piper (Canada) LLP, any of its member firms around the world, or any of its clients. IPPractice.ca grew out of my hobby to gather and share interesting updates on intellectual property to friends and colleagues. This website does not provide legal advice, and should not be relied upon. Hope you enjoy the site - Alan Macek